首页 > 市场调查报告书 > 製药

眼科药物

美洲和欧洲眼药水市场规模和预测（2021 - 2031）、全球和地区份额、趋势和成长机会分析报告范围：按药物类别、应用、购买模式（处方药和非处方药）和地理位置（美国和欧洲）

市场调查报告书

商品编码

1482327

美洲和欧洲眼药水市场规模和预测（2021 - 2031）、全球和地区份额、趋势和成长机会分析报告范围：按药物类别、应用、购买模式（处方药和非处方药）和地理位置（美国和欧洲）

America & Europe Eye Drops Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Application, Purchase Mode (Prescription and OTC), and Geography (America and Europe)

出版日期: 2024年05月03日 | 出版商:

The Insight Partners | 英文 150 Pages | 订单完成后即时交付

价格

简介目录图表

美洲和欧洲滴眼剂市场规模预计将从2023年的131.6亿美元激增至2031年的198.8亿美元；预计 2023 年至 2031 年市场复合年增长率为 5.3%。眼科疾病盛行率的上升和与年龄相关的眼疾的高发病率推动了美国和欧洲眼药水市场的成长。

大多数患有眼睛问题的人都需要特殊的眼药水。这些眼疾可以用眼药水治疗，效果更佳，痛苦也更小。使用这些产品可以有效治疗干眼、红肿、疼痛、搔痒、青光眼、屈光不正、结膜炎、糖尿病黄斑水肿、老年黄斑部病变等症状。滴眼液，也称为人工泪液，是一类常用的治疗药物，透过滋润眼睛并保护眼睛免受进一步感染来同时缓解干眼和发炎的症状。污染、生活方式的改变和长时间看萤幕是导致眼睛疼痛的主要原因。这些因素和环境条件推动了对具有缓解和保护作用的眼药水的需求。无需处方即可购买多种眼药水，这使得顾客更容易购买它们。

眼科疾病盛行率上升推动欧美眼药水市场

糖尿病视网膜病变、青光眼、干眼症（DED）等眼科疾病的发生率在各国尤其已开发国家人口中呈上升趋势。 DED 会带给患者不适、刺激和视力障碍。糖尿病视网膜病变代表微血管终末器官损伤。它从非增殖性糖尿病视网膜病变阶段进展为增殖性糖尿病视网膜病变。随着疾病的进展，相关的糖尿病黄斑水肿（DME）也可能变得明显，导致视力问题和失明。根据《国家健康与保健调查》，截至2020 年4 月，美国约有1,640 万人被检测出患有干眼症。 %。显示，欧洲约有70 万人患有DED。此外，根据欧洲国际糖尿病联盟的数据，20-35% 的糖尿病患者有糖尿病视网膜病变的风险。在欧洲，1 型糖尿病患者的 DME 盛行率约为 8.8%。

白内障在老年人中非常常见，其特征是在眼睛水晶体中形成混浊区域。根据 BMJ 发表的文章《全球白内障手术实践模式：一项调查》，白内障摘除术是所有医学专业中最常见的外科手术，估计美国每年有 370 万例白内障手术，欧洲有 700 万例白内障摘除术。根据欧盟统计局的数据，白内障手术是欧盟最常见的外科手术，2021 年进行了432 万例手术。。

医生通常会开眼药水用于各种眼科疾病的治疗、预防和术后护理。因此，眼科疾病的日益普及推动了美国和欧洲眼药水市场的成长。

市场趋势

生活方式的改变影响眼睛健康

生活方式因素会影响整体健康和福祉。人们每天在食物、健身、户外活动等方面所做的选择会影响他们的老化程度。老化过程也涉及眼睛健康和视力的变化。经常暴露在强烈的阳光下会增加眼部疾病的风险。根据美国眼科学会的数据，暴露在太阳紫外线下会增加黄斑部病变和白内障的风险。超重会透过多种方式增加眼部问题的风险。超重和肥胖会增加糖尿病的风险，从而导致糖尿病视网膜病变和青光眼等疾病导致视力丧失。此外，为改善生活品质而服用的非处方药也会引起与处方药类似的副作用。近年来干眼症病例的迅速增加被认为是由于电脑使用增加而导致长时间接触视觉显示设备（VDT）所致。日常生活的许多方面都会对眼表和眼睛产生不可预见的影响。智慧型手机、笔记型电脑和电脑的使用增加是眼部疾病的主要危险因子之一。因此，这些疾病在整个生活方式疾病类别中占有相当大的份额。因此，增加萤幕时间已成为现代生活方式的重要方面，这也是引发眼睛相关问题的原因。患有慢性眼部疾病和屈光不正的人患数字眼疲劳（DES）的风险更大。 DES 通常表现为不适、干燥、视力模糊和头痛。过度暴露于智慧型手机、平板电脑、iPad 和笔记型电脑萤幕发出的蓝光也会导致严重的眼睛损伤。

在COVID-19大流行期间，所有公司都选择采用在家工作（WFH）模式来控制疾病传播。 WFH的成长趋势增加了专业人士的萤幕时间，进一步加速了与眼睛相关的问题的数量。 Frontiers 发表的一项研究表明，由于过度的调适需求，连续使用数位装置超过两个小时会使用户面临发展 DES 的巨大风险。儘管COVID-19的传播已在很大程度上得到控制，但许多公司仍允许员工继续在家办公，以减少整体支出。从长远来看，这种生活方式的改变最终预计会对眼睛健康产生负面影响，从而在未来产生更大的眼药水需求。

「美国和欧洲眼药水市场」根据药物类别、应用、购买模式和地理位置进行细分。

基于药物类别的见解

依药物类别，欧美眼药水市场分为抗生素、人工泪液、类固醇等。抗生素细分市场在 2023 年占据最大的市场份额。医生会开抗生素眼药水来治疗抗菌感染。这些眼药水的作用首先渗透到眼睛的多个组织层，然后再对感染起作用。在大多数情况下，抗生素眼药水可以立即缓解病情。大多数抗生素眼药水都是安全的且副作用最小。以眼药水形式提供的不同抗生素包括氯霉素、红霉素、阿奇霉素、环丙沙星、新霉素、莫西沙星、妥布霉素、桿菌肽、庆大霉素、多粘菌素B、加替沙星、贝西沙星和左氧氟沙星。除了功效之外，它们在纠正睑板腺功能障碍方面的有益作用也有助于抗生素眼药水市场的成长。

基于应用程式的见解

根据工艺，欧美眼药水市场分为眼疾、眼部保健等。到 2023 年，眼科疾病领域占据最大的市场份额。

美国食品药物管理局、世界卫生组织、疾病管制与预防中心、联合国人口活动基金和全球疾病负担是在准备美国和欧洲的眼睛时参考的一些相关来源放弃市场研究报告。

The America & Europe eye drops market size is projected to surge from US$ 13.16 billion in 2023 to US$ 19.88 billion by 2031; the market is estimated to record a CAGR of 5.3% during 2023-2031. The rising prevalence of ophthalmic diseases and high incidence of age-related eye diseases propel the America & Europe eye drops market growth.

Most people who suffer from eye problems need special eye drops. These eye diseases can be treated with eye drops, which are more effective and less painful. Symptoms such as dry eye, redness, pain, itching, glaucoma, refractive error, conjunctivitis, diabetic macular edema, and age-related macular degeneration can be effectively treated using these products. Eye drops, also called artificial tears, are a class of therapeutics commonly used to simultaneously relieve the symptoms of dry and irritated eyes by moisturizing the eyes and protecting them from further infection. Pollution, changing lifestyles, and prolonged screen time are the prominent causes of eye pain. These factors and environmental conditions propel the demand for eye drops that provide relief and protection. The availability of a wide range of eye drops that can be purchased without a prescription has made it easier for customers to procure them.

Rising Prevalence of Ophthalmic Diseases Drives the America & Europe Eye Drops Market

The Incidence of ophthalmic diseases such as diabetic retinopathy, glaucoma, and dry eye disease (DED) is rising in the populations of various countries, especially the developed ones. DED causes discomfort, irritation, and visual disturbance in patients. Diabetic retinopathy represents microvascular end-organ damage. It progresses from non-proliferative diabetic retinopathy stages to proliferative diabetic retinopathy. As the disease progresses, associated diabetic macular edema (DME) may also become apparent, leading to vision problems and blindness. According to the "National Health and Wellness Survey," ~16.4 million people were detected with dry eye in the US as of April 2020. The study highlights an upsurge in prevalence by 2.7% among people aged 18-34 years during 2020. According to Novaliq GmbH, ~13 million Europeans and ~17 million Americans suffered from DED as of 2023. As per Santen Pharmaceuticals, nearly 11-30% of people in Europe suffered from DED in 2021. Data released on Medscape website states that ~700,000 people in the US suffer from proliferative diabetic retinopathy, with ~65,000 new cases recorded annually. Further, as per the International Diabetes Federation Europe, 20-35% of people with diabetes are at risk of developing diabetic retinopathy. The prevalence of DME in people with type 1 diabetes is approximately 8.8% in Europe.

Cataracts, which are highly common in elderly people, are characterized by the formation of a cloudy area in the eye lens. According to the article "Cataract surgery practice patterns worldwide: a survey," published in BMJ, cataract extraction is the most common surgical procedure in all medical specialties, with an estimated 3.7 million cases per year in the US and 7 million cases reported in Europe. As per Eurostat, cataract surgery was the most common surgical procedure in the EU, with 4.32 million operations in 2021. According to Santen Pharmaceuticals, the number of people suffering from glaucoma is estimated to soar up to ~7.85 million in Europe by 2040.

Doctors generally prescribe eye drops for the treatment, prevention, and post-surgical care of various ophthalmic diseases. Hence, the increasing prevalence of ophthalmic diseases fuels the America & Europe eye drops market growth.

Market Trend

Lifestyle Changes Affecting Eye Health

Lifestyle factors can impact the overall health and well-being. The choices made by people every day with regard to their food, fitness, outdoor activities, etc., affect how well they age. The aging process also involves changes in eye health and vision. Heavy sun exposure on a frequent basis can increase the risk of developing eye diseases. As per the American Academy of Ophthalmology, exposure to the sun's UV rays can increase the risk of macular degeneration and cataracts. Being overweight can increase the risk of eye problems in several ways. Overweight and obesity increase the risk of developing diabetes, which can lead to vision loss from diseases such as diabetic retinopathy and glaucoma. Further, non-prescription medications taken to improve quality of life can also cause side effects similar to those of prescription medications. The rapid increase in DED cases in recent years is believed to be due to prolonged exposure to visual display devices (VDT) caused by increasing computer use. Many aspects of everyday life can have unforeseen effects on the ocular surface and the eye. The increased use of smartphones, laptops, and computers is one of the key risk factors for eye diseases. Hence, these diseases hold a substantial share of the overall category of lifestyle diseases. Thus, increased screen time has become an important aspect of a modern lifestyle, which is responsible for triggering eye-related problems. Individuals with chronic eye conditions and refractive errors are at a greater risk of developing digital eye strain (DES). DES often manifests as discomfort, dryness, blurred vision, and headaches. Extreme exposure to blue rays emitted from smartphone, tablet, iPad, and laptop screens also causes serious eye damage.

During the COVID-19 pandemic, all companies opted to adopt the work-from-home (WFH) model to control the disease spread. The growing trend of WFH has intensified the screen time of working professionals, further accelerating the number of eye-related issues. According to a study published by Frontiers, the constant use of digital devices for more than two continuous hours puts users at a great risk of developing DES owing to the excessive accommodative demands. Although the spread of COVID-19 has been controlled to a large extent, many companies have allowed their employees to continue with WFH to decrease the overall expenditure. Such lifestyle changes are eventually expected to have negative effects on eye health in the long run, generating a greater demand for eye drops in the future.

The "America & Europe Eye Drops Market" is segmented on the basis of drug class, application, purchase mode, and geography.

Drug Class-Based Insights

Based on drug class, the America & Europe eye drops market is segmented into antibiotics, artificial tears, steroids, and others. The antibiotics segment held the largest market share in 2023. However, the steroids segment is anticipated to register the highest CAGR of 6.4% during the forecast period. Antibiotic eye drops are prescribed by doctors to treat antibacterial infections. The action of these eye drops starts with the penetration of multiple tissue layers of the eye before acting on the infection. In most cases, antibiotic eye drops provide immediate relief from the condition. Most antibiotic eye drops are safe and have minimal side effects. Different antibiotics that are offered in the form of eye drops include chloramphenicol, erythromycin, azithromycin, ciprofloxacin, neomycin, moxifloxacin, tobramycin, bacitracin, gentamycin, polymyxin B, gatifloxacin, besifloxacin, and levofloxacin. In addition to their efficacy, their beneficial role in rectifying the malfunctioning of meibomian glands contributes to the growth of the market for antibiotic eye drops.

Application-Based Insights

Based on process, the America & Europe eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest market share in 2023. However, the eye care segment is anticipated to register the highest CAGR during the forecast period.

US Food and Drug Administration, World Health Organization, Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, United Nations Fund for Population Activities, and Global Burden of Disease are some of the relevant sources referred while preparing the America & Europe eye drops market research report.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. America and Europe Eye Drops Market Landscape

4.1 Overview
4.2 PEST Analysis

5. America and Europe Eye Drops Market - Key Market Dynamics

5.1 America and Europe Eye Drops Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Ophthalmic Diseases
- 5.2.2 High Incidence of Age-Related Eye Diseases
5.3 Market Restraints
- 5.3.1 Rising Number of Product Recalls
5.4 Market Opportunities
- 5.4.1 Initiatives to Bolster Eye Care Awareness
5.5 Future Trends
- 5.5.1 Lifestyle Changes Affecting Eye Health
5.6 Impact:

6. America and Europe Eye Drops Market - Regional Market Analysis

6.1 America and Europe Eye Drops Market Revenue (US$ Million), 2023-2031

7. America and Europe Eye Drops Market Analysis - by Drug Class

7.1 Overview
7.2 Antibiotics
- 7.2.1 Overview
- 7.2.2 Antibiotics: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Artificial Tears
- 7.3.1 Overview
- 7.3.2 Artificial Tears: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Steroids
- 7.4.1 Overview
- 7.4.2 Steroids: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)

8. America and Europe Eye Drops Market Analysis - by Application

8.1 Overview
8.2 Eye Diseases
- 8.2.1 Overview
- 8.2.2 Eye Diseases: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Eye Care
- 8.3.1 Overview
- 8.3.2 Eye Care: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)

9. America and Europe Eye Drops Market Analysis - by Purchase Mode

9.1 Overview
9.2 Prescription
- 9.2.1 Overview
- 9.2.2 Prescription: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
9.3 OTC
- 9.3.1 Overview
- 9.3.2 OTC: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)

10. America and Europe Eye Drops Market - Geographical Analysis

10.1 Overview
10.2 America
- 10.2.1 America Eye Drops Market Overview
- 10.2.2 America: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
  - 10.2.2.1 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Drug Class
    - 10.2.2.1.1 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Antibiotics
    - 10.2.2.1.2 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Artificial Tears
    - 10.2.2.1.3 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Steroids
  - 10.2.2.2 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Application
    - 10.2.2.2.1 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Eye Diseases
  - 10.2.2.3 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Purchase Mode
- 10.2.3 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Country
  - 10.2.3.1 United States: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.1.1 Overview
    - 10.2.3.1.2 United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.1.3 United States: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.2.3.1.3.1 United States: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.2.3.1.3.2 United States: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.2.3.1.3.3 United States: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.2.3.1.4 United States: America and Europe Eye Drops Market Breakdown, by Application
    - 10.2.3.1.4.1 United States: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.2.3.1.5 United States: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.2.3.2 Canada: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.2.1 Overview
    - 10.2.3.2.2 Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.2.3 Canada: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.2.3.2.3.1 Canada: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.2.3.2.3.2 Canada: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.2.3.2.3.3 Canada: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.2.3.2.4 Canada: America and Europe Eye Drops Market Breakdown, by Application
    - 10.2.3.2.4.1 Canada: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.2.3.2.5 Canada: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.2.3.3 Brazil: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.3.1 Overview
    - 10.2.3.3.2 Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.3.3 Brazil: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.2.3.3.3.1 Brazil: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.2.3.3.3.2 Brazil: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.2.3.3.3.3 Brazil: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.2.3.3.4 Brazil: America and Europe Eye Drops Market Breakdown, by Application
    - 10.2.3.3.4.1 Brazil: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.2.3.3.5 Brazil: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.2.3.4 Mexico: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.4.1 Overview
    - 10.2.3.4.2 Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.4.3 Mexico: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.2.3.4.3.1 Mexico: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.2.3.4.3.2 Mexico: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.2.3.4.3.3 Mexico: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.2.3.4.4 Mexico: America and Europe Eye Drops Market Breakdown, by Application
    - 10.2.3.4.4.1 Mexico: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.2.3.4.5 Mexico: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.2.3.5 Argentina: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.5.1 Overview
    - 10.2.3.5.2 Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.5.3 Argentina: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.2.3.5.3.1 Argentina: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.2.3.5.3.2 Argentina: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.2.3.5.3.3 Argentina: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.2.3.5.4 Argentina: America and Europe Eye Drops Market Breakdown, by Application
    - 10.2.3.5.4.1 Argentina: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.2.3.5.5 Argentina: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.2.3.6 Chile: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.6.1 Overview
    - 10.2.3.6.2 Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.6.3 Chile: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.2.3.6.3.1 Chile: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.2.3.6.3.2 Chile: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.2.3.6.3.3 Chile: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.2.3.6.4 Chile: America and Europe Eye Drops Market Breakdown, by Application
    - 10.2.3.6.4.1 Chile: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.2.3.6.5 Chile: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.2.3.7 Rest of America: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.7.1 Overview
    - 10.2.3.7.2 Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.7.3 Rest of America: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.2.3.7.3.1 Rest of America: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.2.3.7.3.2 Rest of America: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.2.3.7.3.3 Rest of America: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.2.3.7.4 Rest of America: America and Europe Eye Drops Market Breakdown, by Application
    - 10.2.3.7.4.1 Rest of America: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.2.3.7.5 Rest of America: America and Europe Eye Drops Market Breakdown, by Purchase Mode
10.3 Europe
- 10.3.1 Overview
- 10.3.2 Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
  - 10.3.2.1 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Drug Class
    - 10.3.2.1.1 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Antibiotics
    - 10.3.2.1.2 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Artificial Tears
    - 10.3.2.1.3 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Steroids
  - 10.3.2.2 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Application
    - 10.3.2.2.1 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Eye Diseases
  - 10.3.2.3 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Purchase Mode
- 10.3.3 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Country
  - 10.3.3.1 Germany: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.1.1 Overview
    - 10.3.3.1.2 Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.1.3 Germany: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.3.3.1.3.1 Germany: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.3.3.1.3.2 Germany: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.3.3.1.3.3 Germany: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.3.3.1.4 Germany: America and Europe Eye Drops Market Breakdown, by Application
    - 10.3.3.1.4.1 Germany: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.3.3.1.5 Germany: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.3.3.2 France: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.2.1 Overview
    - 10.3.3.2.2 France: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.2.3 France: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.3.3.2.3.1 France: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.3.3.2.3.2 France: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.3.3.2.3.3 France: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.3.3.2.4 France: America and Europe Eye Drops Market Breakdown, by Application
    - 10.3.3.2.4.1 France: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.3.3.2.5 France: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.3.3.3 United Kingdom: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.3.1 Overview
    - 10.3.3.3.2 United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.3.3 United Kingdom: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.3.3.3.3.1 United Kingdom: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.3.3.3.3.2 United Kingdom: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.3.3.3.3.3 United Kingdom: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.3.3.3.4 United Kingdom: America and Europe Eye Drops Market Breakdown, by Application
    - 10.3.3.3.4.1 United Kingdom: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.3.3.3.5 United Kingdom: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.3.3.4 Italy: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.4.1 Overview
    - 10.3.3.4.2 Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.4.3 Italy: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.3.3.4.3.1 Italy: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.3.3.4.3.2 Italy: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.3.3.4.3.3 Italy: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.3.3.4.4 Italy: America and Europe Eye Drops Market Breakdown, by Application
    - 10.3.3.4.4.1 Italy: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.3.3.4.5 Italy: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.3.3.5 Spain: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.5.1 Overview
    - 10.3.3.5.2 Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.5.3 Spain: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.3.3.5.3.1 Spain: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.3.3.5.3.2 Spain: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.3.3.5.3.3 Spain: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.3.3.5.4 Spain: America and Europe Eye Drops Market Breakdown, by Application
    - 10.3.3.5.4.1 Spain: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.3.3.5.5 Spain: America and Europe Eye Drops Market Breakdown, by Purchase Mode
  - 10.3.3.6 Rest of Europe: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.6.1 Overview
    - 10.3.3.6.2 Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.6.3 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Drug Class
    - 10.3.3.6.3.1 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Antibiotics
    - 10.3.3.6.3.2 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Artificial Tears
    - 10.3.3.6.3.3 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Steroids
    - 10.3.3.6.4 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Application
    - 10.3.3.6.4.1 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Eye Diseases
    - 10.3.3.6.5 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Purchase Mode

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the America and Europe Eye Drops Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Alcon AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 AbbVie Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Bausch & Lomb Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Pfizer Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Prestige Consumer Healthcare Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Similasan Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Rohto Pharmaceutical Co Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Sager Pharma Kft
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Akorn Operating Company LLC
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Santen Pharmaceutical Co., Ltd.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 SERVImed Industrial S.p.A.
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 I-MED Pharma Inc.
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments

13. Appendix

13.1 About The Insight Partners

简介目录图表

List Of Tables

Table 1. America and Europe Eye Drops Market Segmentation
Table 2. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 3. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 4. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 5. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 6. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 7. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 8. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 9. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 10. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 11. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 12. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 13. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 14. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 15. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 16. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 17. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 18. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 19. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 20. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 21. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 22. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 23. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 24. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 25. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 26. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 27. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 28. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 29. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 30. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 31. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 32. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 33. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 34. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 35. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 36. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 37. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 38. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 39. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 40. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 41. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 42. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 43. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 44. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 45. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 46. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 47. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 48. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 49. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 50. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 51. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 52. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 53. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 54. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 55. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 56. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 57. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 58. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 59. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 60. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 61. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 62. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 63. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 64. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 65. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 66. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 67. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 68. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 69. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 70. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 71. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 72. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 73. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 74. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 75. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 76. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 77. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 78. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 79. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 80. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 81. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 82. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 83. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 84. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 85. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 86. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 87. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 88. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 89. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 90. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 91. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 92. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 93. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 94. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 95. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 96. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 97. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 98. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 99. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 100. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 101. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
Table 102. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
Table 103. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
Table 104. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 105. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
Table 106. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
Table 107. Recent Organic Growth Strategies in the America and Europe Eye Drops Market
Table 108. Recent Inorganic Growth Strategies in the America and Europe Eye Drops Market

List Of Figures

Figure 1. America and Europe Eye Drops Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. America and Europe Eye Drops Market Revenue (US$ Million), 2023-2031
Figure 5. Eye Drops Market Breakdown by Geography, 2023 and 2031 (%)
Figure 6. America and Europe Eye Drops Market Share (%) - by Drug Class (2023 and 2031)
Figure 7. Antibiotics: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Artificial Tears: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Steroids: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Others: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. America and Europe Eye Drops Market Share (%) - by Application (2023 and 2031)
Figure 12. Eye Diseases: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Eye Care: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Others: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. America and Europe Eye Drops Market Share (%) - by Purchase Mode (2023 and 2031)
Figure 16. Prescription: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. OTC: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. America and Europe Eye Drops Market Breakdown by Region, 2023 and 2031 (%)
Figure 19. America: Eye Drops Market, by Key Country - Revenue (2023) (US$ Million)
Figure 20. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 21. America: America and Europe Eye Drops Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 22. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 23. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 25. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 26. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 27. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 28. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 29. Europe: Eye Drops Market, by Key Country - Revenue (2023) (US$ Million)
Figure 30. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 31. Europe: America and Europe Eye Drops Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 32. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 33. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 34. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 35. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 36. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 37. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
Figure 38. Growth Strategies in the America and Europe Eye Drops Market